New Genomic Techniques (NGT) - Genome Editing
- Current genetic engineering legislation reduces the willingness to invest in research. Much
needed climate- and disease-resilient, higher-yielding and healthier plants cannot be bred in
a timely manner.
- The loss of research funding threatens a massive loss of know-how in Germany and Europe.
- The use of the potential of NGT is increasingly becoming the privilege of a small group of
financially strong multinational corporations. This makes investment in research and
development in Europe unattractive. European research will fall behind in international
competition.
Contact:
WGG: zentrale@wgg-ev.de,
VBIO: berlin@vbio.de
13.10.2022